BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 15, 2006
View Archived Issues
Snapshots of endocrine therapy presentations from ASCO
Read More
PharmAthene and SIGA Technologies to merge
Read More
PTC Therapeutics and CV Therapeutics establish research collaboration
Read More
SPI-1005 begins clinical testing for noise induced hearing loss
Read More
Cephalon and Takeda to copromote Provigil
Read More
CP-751871 assessed in phase I cancer trials
Read More
TAS-102 regimens assessed in phase I cancer studies
Read More
Galapagos to acquire DPI's drug discovery service operations
Read More
Novartis and Intercell sign Japanese encephalitis vaccine agreement
Read More
Somatostatin sst4 receptor agonists as new prospects for pain therapy / News in Context
Read More
Talotrexin evaluated in phase I trials in solid tumors and non-small cell lung cancer
Read More
Study determines phase II regimen of SB-743921 in patients with solid tumors
Read More
Clinical trial results for gimatecan presented at ASCO meeting
Read More
Snapshots of clinical trials of heat shock protein 90 inhibitors presented at ASCO 2006
Read More
CPT-L2-BA3 targets bombesin receptors to induce cytotoxicity in several human cancers
Read More
Almirall and Meda form strategic partnership over inhalation products division
Read More
Phase II data for antithrombosis drug BAY-59-7939 support entry to phase III
Read More
Maturation inhibitor bevirimat begins phase IIb study
Read More
Preclinical findings for Lipoxen's vaccine delivery technology ImuXen
Read More
Clavis cleared for phase I study of CP-4126 in solid tumors
Read More
New asthma compound enters phase IIb from Beyond Advair collaboration
Read More
MediciNova begins development of MN-221 for status asthmaticus
Read More
Ceflatonin studied in CML patients with T315I mutation
Read More
MyVax personalized immunotherapy receives fast track status for follicular NHL
Read More
SPA for phase II/III study of Bexidem in superficial bladder cancer
Read More
Fast track designation for Nexavar in metastatic hepatocellular carcinoma
Read More
New orphan drug designations for rhC1INH
Read More
Recent patents cover novel therapeutic agents for neurological disorders
Read More
Vivitrol for alcohol dependence now available
Read More
Novel treatment options for metabolic disorders described in recent patents
Read More
Antigenics presents preclinical data on its novel genital herpes vaccine
Read More
Novel insulin sensitizing syncretic drug developed at CombinatoRx shows antidiabetic activity in rat
Read More
FG-3019 prevents diabetes-induced cardiovascular complications in diabetic rats
Read More
Preclinical findings on metaglidasen presented by Metabolex
Read More